...Yang Liu; Lei Wen; Huan Chen; Yao Chen; Wenbing Duan; Ying Kang; Ling Ma; Xiaojun Huang; Jin Lu Background: Serum lactate dehydrogenase (LDH) is an adverse prognostic factor for newly diagnosed multiple myeloma (MM). However, the role of LDH in the prognosis of MM patients with relapse has not yet...

...Junshik Hong; Hyun-Hwa Yoon; Hee Kyung Ahn; Sun Jin Sym; Jinny Park; Pil-Whan Park; Jeong Yeal Ahn; Sanghui Park; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee Background/Aims: Baseline serum lactate dehydrogenase (LDH) level is a well-known prognostic factor in patients with non-Hodgkin's lymphoma...

...Oula Abdullah Najim; Mea’ad Kadhum Hassan Objectives: This prospective study was carried out to assess lactate dehydrogenase (LDH) as a biochemical marker during acute painful episode and steady state in children with sickle cell disease (SCD). Design and Methods: A prospective descriptive study...

...Gianpiero Fasola; Renato Fanin; Filíppo Gherlinzoni; Piero Galieni; Domenica Taruscio; Giovanni Frezza; Patrizio Mazza; Stefano Pileri; Michele Baccarani Serum lactate dehydrogenase (LDH) activity is increased in many tumor-bearing patients and can be used as a prognostic marker. We studied serum...

...Osamu Kabutomori; Yuzuru Kanakura; Yoshinori Iwatani We examined the clinical usefulness of 3 parameters of routine laboratory tests [platelet-large cell ratio (P-LCR), lactate dehydrogenase (LDH) and C-reactive protein (CRP)] in 84 patients with thrombocytosis-related diseases (reactive...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Granulocyte-colony-stimulating factor Lactate dehydrogenase Isoenzymes In the control group, no change was observed in LDH levels and leukocyte counts in consecutive samples...